Morellato’s Massimo Carraro: “I do not rule out further acquisitions or a future stock exchange listing”

Published November 14, 2025 From the stage of the 30th Pambianco Fashion Summit, Massimo Carraro, chairman of Morellato Group, outlined the strengths and future goals of the €723 million group (financial year ended last February) he leads, whose origins date back to 1930, when it began as a small jewellery and watch workshop. Massimo Carraro…

Read More

Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford

About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds. Overall nearly one…

Read More

KFF Health Tracking Poll: Prescription Drug Costs, Views on Trump Administration Actions, and GLP-1 Use

Key Takeaways With the Trump administration recently announcing several high-profile prescription drug pricing deals, the latest polling from KFF suggests that few think it is likely the Trump administration’s actions will lower their prescription drug costs, but his base remains more positive. Large majorities of Republicans (73%) and MAGA-supporting Republicans (83%) say they think it…

Read More

Richemont hails “solid” Q2, Alaïa and Peter Millar are strong, improved momentum at Chloé.

Published November 14, 2025 Luxury giant Richemont hasn’t been performing badly in recent periods with its last set of annual results this spring being generally good and its Q1 numbers in July showing it making progress. See fashion showChloe – Fall-Winter2025 – 2026 – Womenswear – France – Paris – ©Launchmetrics/spotlight But there have been…

Read More